Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 0.03 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 0.12 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 0.02 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 0.11 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 0.36 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 0.0 | BCD100322A001 | 0.08 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 0.5 | BCD100322A003 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 1.0 | BCD100322A007 | 0.13 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 2.0 | BCD100322A011 | 0.03 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 4.0 | BCD100322A015 | 0.18 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 8.0 | BCD100322A019 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 12.0 | BCD100322A023 | 0.04 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 24.0 | BCD100322A027 | 0.19 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 0.01 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 0.21 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 0.28 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 0.66 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 0.5 | BCD100322A004 | 0.07 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 1.0 | BCD100322A008 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 2.0 | BCD100322A012 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 4.0 | BCD100322A016 | - | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 8.0 | BCD100322A020 | 0.12 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 12.0 | BCD100322A024 | 0.39 | pmol/ug DNA |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 24.0 | BCD100322A028 | 0.54 | pmol/ug DNA |